Exact Sciences
EXAS
#1382
Rank
S$17.04 B
Marketcap
$92.26
Share price
2.34%
Change (1 day)
-10.31%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -S$0.21 B

According to Exact Sciences's latest financial reports the company's current earnings (TTM) are -S$0.21 B. In 2023 the company made an earning of -S$0.25 B an increase over its 2022 earnings that were of -S$0.81 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.21 B-14.02%
2023 -S$0.25 B-69.98%
2022 -S$0.81 B-25.55%
2021 -S$1.09 B1.68%
2020 -S$1.07 B271.17%
2019 -S$0.29 B58.99%
2018 -S$0.19 B20.89%
2017 -S$0.15 B-30.95%
2016 -S$0.22 B5.09%
2015 -S$0.21 B57.24%
2014 -S$0.14 B116.53%
2013 -S$60.31 M
2011 -S$37.55 M143.73%
2010 -S$15.41 M27.85%
2009 -S$12.05 M0.27%
2008 -S$12.02 M-20.95%
2007 -S$15.21 M-13.53%
2006 -S$17.58 M-10.07%
2005 -S$19.55 M-21.81%
2004 -S$25.01 M-33.44%
2003 -S$37.57 M-6.51%
2002 -S$40.18 M17.95%
2001 -S$34.07 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.2 B-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
S$85.81 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$71.37 M-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$45.55 M-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.79 B-4,458.48%๐Ÿ‡ซ๐Ÿ‡ท France